Brief: Zydus Lifesciences Approval From China’S Nmpa For Venlafaxine Extended-Release Capsules
Nov 11 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: APPROVAL FROM CHINA’S NMPA FOR VENLAFAXINE EXTENDED-RELEASE CAPSULES VENLAFAXINE ER CAPSULES TO BE PRODUCED AT AHMEDABAD FACILITY Further company coverage: ZYDU.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka